Search results for "Opioids"
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Extended-release naltrexone may be as effective as buprenorphine but more difficult to initiate
Buprenorphine might be a safer initial strategy for many patients because of the better chance of a quick, successful induction, a comment author noted.
https://immattersacp.org/weekly/archives/2017/11/21/2.htm
21 Nov 2017
Register now for ACP's one-day course on pain management in an environment of opioid de-escalation
The virtual course on Tuesday, Oct. 5, will provide education for internists on the latest strategies and best practices in pain management.
https://immattersacp.org/weekly/archives/2021/09/21/5.htm
21 Sep 2021
Mortality in year after overdose lower with methadone or buprenorphine treatment
Compared with no medications for opioid use disorder, methadone and buprenorphine were each associated with decreased all-cause and opioid-related mortality.
https://immattersacp.org/weekly/archives/2018/06/19/1.htm
19 Jun 2018
Palliative care's place outside cancer
Integrated palliative care is important in offering comfort measures to patients with conditions that are expected to shorten their life spans.
https://immattersacp.org/archives/2019/06/palliative-cares-place-outside-cancer.htm
1 Jun 2019
Dabigatran recalled, dense-breast notification required
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/05/dabigatran-recalled-dense-breast-notification-required.htm
1 May 2023
Evidence lacking on efficacy of prescription drug monitoring programs
Features of prescription drug monitoring programs associated with reductions in overdoses included mandatory review of data by clinicians before writing prescriptions, frequent (at least weekly) updates of data, clinician authorization to access data, and monitoring of nonscheduled drugs.
https://immattersacp.org/weekly/archives/2018/05/08/1.htm
8 May 2018
Increasing rates of chronic pain found among those who die by suicide
Among suicide decedents included in the study, 8.8% had evidence of chronic pain, and the percentage increased from 7.4% in 2003 to 10.2% in 2014.
https://immattersacp.org/weekly/archives/2018/09/11/1.htm
11 Sep 2018
CBT intervention reduced pain and disability but not opioid use in patients with chronic pain
While the effects of a cognitive behavioral therapy (CBT) intervention in primary care were modest, this type of intervention may be an attractive option, given the limited efficacy and safety of long-term opioid treatment, the trial authors concluded.
https://immattersacp.org/weekly/archives/2021/11/02/2.htm
2 Nov 2021
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023